SARS に関する基本情報

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

SARS に関する基本情報

Published Date:

2004年1月13日

Language:

[PDF - 374.23 KB]

Details:

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Series:

重症急性呼吸器症候群資料 ; Severe acute respiratory syndrome fact sheet ;

Description:

Basic Information about SARS [Japanese]

fs-sars-ja.pdf

Document Type:

Pamphlet (or booklet)

Collection(s):

Stephen B. Thacker CDC Library collection

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

SARS

Corporate Author:

Centers for Disease Control and Prevention (U.S.). David J. Sencer CDC Museum.

Published:

10/28/09

Series:

Infectious disease trading cards ; series 1

Description:

Part of series 1 of the CDC Museum set of Infectious disease trading cards, featuring photos and information about some of the infectious diseases that CDC studies. : SARS stands for Severe Acute Respiratory Syndrome. SARS is caused by a virus that i...

File Type:

[PDF - 81.29 KB]
SARS Coronavirus Detection

Personal Author:

Nitsche, Andreas; Schweiger, Brunhilde; Ellerbrok, Heinz; Niedrig, Matthias; Pauli, Georg;

Published:

Jul 2004

Source:

Emerg Infect Dis. 10(7):1300-1303.

Description:

We developed a set of three real-time reverse transcription-polymerase chain reaction (PCR) assays that amplify three different regions of the SARS-associated coronavirus (SARS-CoV), can be run in parallel or in a single tube, and can detect <10 geno...

File Type:

[PDF - 185.56 KB]
SARS Epidemiology Modeling

Personal Author:

Hsieh, Ying-Hen; Lee, Jen-Yu; Chang, Hsiao-Ling;

Published:

Jun 2004

Source:

Emerg Infect Dis. 10(6):1165-1167.

File Type:

[PDF - 98.76 KB]
SARS Alert Applicability

Published:

Aug 2004

Source:

Emerg Infect Dis. 10(8):1512-1514.

File Type:

[PDF - 84.43 KB]
SARS Vaccine Development

Personal Author:

Jiang, Shibo; He, Yuxian; Liu, Shuwen;

Published:

Jul 2005

Source:

Emerg Infect Dis. 11(7):1016-1020.

Description:

Developing effective and safe vaccines is urgently needed to prevent infection by severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV). The inactivated SARS-CoV vaccine may be the first one available for clinical use because it ...

File Type:

[PDF - 95.26 KB]